Guild BioSciences

Guild BioSciences is a bioscience technology development business unit of Guild Associates, located in Dublin, Ohio. The company employs 10 people and generates approximately $11 million in annual revenue. Guild BioSciences focuses on the development and commercialization of innovative bioscience technology across three key areas: Diagnostics, Therapeutics, and Specialty Biomaterials. They offer M13mp18 based ssDNA scaffolds used by the DNA Origami research community. Additionally, their patented ImmobiZyme™ technology provides low-cost enzyme immobilization solutions utilizing novel support materials, including biodegradable options, customizable to meet diverse property requirements. The company actively engages in research and development, securing funding from various government agencies such as the Department of Defense, National Institutes of Health, United States Department of Agriculture, and National Science Foundation. Guild BioSciences collaborates with universities, commercial companies, and government agencies to advance its technological innovations. For more information, visit guildbiosciences.com.